Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yigansan in Children and Adolescents With Tourette's Disorder
NCT03564132Phase 2Completed
- Sponsor
- China Medical University Hospital
- Start
- Jun 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Tourette syndrome (TS) comparing Yigansan with Placebo (2 arms). Primary endpoint: Yale Global Tic Severity Scale Total Tic Score at 4 weeks. Started Jun 2018; status: completed.
02
Drugs
yokukansan
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT03564132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03564132.